MakarovaKS, AravindL, GrishinNV, et al.A DNA repair system specific for thermophilic Archaea and bacteria predicted by genomic context analysis. Nucleic Acids Res, 2002; 30(2):482–496; doi: 10.1093/nar/30.2.482
2.
ChiH, HoikkalaV, GrüschowS, et al.Antiviral type III CRISPR signalling via conjugation of ATP and SAM. Nature, 2023; 622(7984):826–833; doi: 10.1038/s41586-023-06620-5
3.
HoikkalaV, GrahamS, WhiteMF. Bioinformatic analysis of type III CRISPR systems reveals key properties and new effector families. Nucleic Acids Res, 2024; 52(12):7129–7141; doi: 10.1093/nar/gkae462
4.
WhymsC, ZhaoY, Addo-YoboD, et al.A CRISPR-associated Rossman-fold ring nuclease and adenosine deaminase fusion allosterically converts ATP to ITP. bioRxiv, 2024; doi: 10.1101/2024.12.12.628194
5.
GaoY, LuoX, LiP, et al.Molecular basis of RADAR anti-phage supramolecular assemblies. Cell, 2023; 186(5):999–1012.e20; doi: 10.1016/j.cell.2023.01.026
6.
Duncan-LoweyB, TalN, JohnsonAG, et al.Cryo-EM structure of the RADAR supramolecular anti-phage defense complex. Cell, 2023; 186(5):987–998.e15; doi: 10.1016/j.cell.2023.01.012
7.
AviramN, ShiltonAK, LynNG, et al.Cas10 relieves host growth arrest to facilitate spacer retention during type III-A CRISPR-Cas immunity. Cell Host Microbe, 2024; 32(12):2050–2062.e6; doi: 10.1016/j.chom.2024.11.005
8.
WanderaKG, SchmelzS, MigurA, et al.AcrVIB1 inhibits CRISPR-Cas13b immunity by promoting unproductive crRNA binding accessible to RNase attack. Mol Cell, 2025; 85(6):1162–1175.e7; doi: 10.1016/j.molcel.2025.01.020
9.
MarinoND, TalaieA, CarionH, et al.Translation-Dependent downregulation of Cas12a mRNA by an Anti-CRISPR protein. bioRxiv, 2022; doi: 10.1101/2022.11.29.518452
10.
KrupovicM, Cvirkaite-KrupovicV, IranzoJ, et al.Viruses of archaea: Structural, functional, environmental and evolutionary genomics. Virus Res, 2018; 244:181–193; doi: 10.1016/j.virusres.2017.11.025
11.
WilkinsonM, DrabaviciusG, SilanskasA, et al.Structure of the DNA-Bound spacer capture complex of a Type II CRISPR-Cas system. Mol Cell, 2019; 75(1):90–101.e5; doi: 10.1016/j.molcel.2019.04.020
12.
MargolisSR, MeeskeAJ. Crosstalk between Three CRISPR-Cas types enables primed type VI-A adaptation in Listeria Seeligeri. bioRxiv, 2024; 2024(10.25.620265); doi: 10.1101/2024.10.25.620265
13.
HibshmanGN, TaylorDW. Structural basis for a dual-function type II-B CRISPR-Cas9. bioRxiv, 2025; doi: 10.1101/2024.10.22.619592
14.
SampsonTR, SarojSD, LlewellynAC, et al.A CRISPR/Cas system mediates bacterial innate immune evasion and virulence. Nature, 2013; 497(7448):254–257; doi: 10.1038/nature12048
15.
HallmarkT, KunwarS, MannaS, et al.RNA-Triggered CRISPR-Cas12a2 preferentially and cooperatively cleaves collateral DNA. bioRxiv, 2025; 2025(01.05.631166); doi: 10.1101/2025.01.05.631166
16.
AckermanCM, MyhrvoldC, ThakkuSG, et al.Massively multiplexed nucleic acid detection with Cas13. Nature, 2020; 582(7811):277–282; doi: 10.1038/s41586-020-2279-8
17.
WelchNL, ZhuM, HuaC, et al.Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants. Nat Med, 2022; 28(5):1083–1094; doi: 10.1038/s41591-022-01734-1
18.
MetskyHC, WelchNL, PillaiPP, et al.Designing sensitive viral diagnostics with machine learning. Nat Biotechnol, 2022; 40(7):1123–1131; doi: 10.1038/s41587-022-01213-5
19.
KangB, ZhangJ, SchwoererMP, et al.Highly multiplexed mRNA quantitation with CRISPR-Cas13. bioRxiv, 2023; doi: 10.1101/2023.08.16.553527
20.
KellnerMJ, KoobJG, GootenbergJS, et al.SHERLOCK: Nucleic acid detection with CRISPR nucleases. Nat Protoc, 2019; 14(10):2986–3012.
21.
CoxDBT, GootenbergJS, AbudayyehOO, et al.RNA editing with CRISPR-Cas13. Science, 2017; 358(6366):1019–1027.
22.
GuptaR, GhoshA, ChakravartiR, et al.Cas13d: A new molecular scissor for transcriptome engineering. Front Cell Dev Biol, 2022; 10:866800; doi: 10.3389/fcell.2022.866800
23.
SahuSU, CastroM, MuldoonJJ, et al.Peptide-enabled ribonucleoprotein delivery for CRISPR engineering (PERC) in primary human immune cells and hematopoietic stem cells. Nat Protoc, 2025; doi: 10.1038/s41596-025-01154-8
24.
KreitzJ, FriedrichMJ, GuruA, et al.Programmable protein delivery with a bacterial contractile injection system. Nature, 2023; 616(7956):357–364; doi: 10.1038/s41586-023-05870-7
25.
LonghurstHJ, LindsayK, PetersenRS, et al.CRISPR-Cas9 in vivo gene editing of KLKB1 for hereditary angioedema. N Engl J Med, 2024; 390(5):432–441; doi: 10.1056/NEJMoa2309149
26.
MeadenS, WestraE, FineranP. Phage defence system abundances vary across environments and increase with viral density. bioRxiv, 2025; 2025(01.16.633327); doi: 10.1101/2025.01.16.633327
27.
MeadenS, BiswasA, ArkhipovaK, et al.High viral abundance and low diversity are associated with increased CRISPR-Cas prevalence across microbial ecosystems. Curr Biol, 2022; 32(1):220–227.e5; doi: 10.1016/j.cub.2021.10.038
28.
MearsKS, RossineFW, Quinones-OlveraN, et al.RNA-Guided nucleases enable a gene drive of insertion sequences in plasmids. bioRxiv, 2025; doi: 10.1101/2025.02.20.638934
29.
SamuelB, MittelmanK, CroitoruSY, et al.Diverse anti-defence systems are encoded in the leading region of plasmids. Nature, 2024; 635(8037):186–192; doi: 10.1038/s41586-024-07994-w
30.
Zilberzwige-TalS, Altae-TranH, KannanS, et al.Reprogrammable RNA-targeting CRISPR systems evolved from RNA toxin-antitoxins. Cell, 2025; 188(7):1925–1940.e20; doi: 10.1016/j.cell.2025.01.034
31.
PayneLJ, MeadenS, MestreMR, et al.PADLOC: A web server for the identification of antiviral defence systems in microbial genomes. Nucleic Acids Res, 2022; 50(W1):W541–W550; doi: 10.1093/nar/gkac400
32.
TessonF, HervéA, MordretE, et al.Systematic and quantitative view of the antiviral arsenal of prokaryotes. Nat Commun, 2022; 13(1):2561; doi: 10.1038/s41467-022-30269-9
33.
DeWeirdtPC, MahoneyEM, LaubMT. DefensePredictor: A machine learning model to discover novel prokaryotic immune systems. bioRxiv, 2025; doi: 10.1101/2025.01.08.631726
34.
BurmanN, BelukhinaS, DepardieuF, et al.A virally encoded tRNA neutralizes the PARIS antiviral defence system. Nature, 2024; 634(8033):424–431; doi: 10.1038/s41586-024-07874-3
35.
MillmanA, MelamedS, LeavittA, et al.An expanded arsenal of immune systems that protect bacteria from phages. Cell Host Microbe, 2022; 30(11):1556–1569.e5; doi: 10.1016/j.chom.2022.09.017
36.
MordretE, HervéA, VayssetH, et al.Protein and genomic language models chart a vast landscape of antiphage defenses. bioRxiv, 2025; doi: 10.1101/2025.01.08.631966
37.
DoronS, MelamedS, OfirG, et al.Systematic discovery of antiphage defense systems in the microbial pangenome. Science, 2018; 359(6379); doi: 10.1126/science.aar4120
38.
LiJ, ChengR, WangZ, et al.Structures and activation mechanism of the Gabija anti-phage system. Nature, 2024; 629(8011):467–473; doi: 10.1038/s41586-024-07270-x
